Adjuvant Therapeutics Overview

  • Status
  • Out of Business

  • Employees
  • 1

  • Latest Deal Type
  • Out of Business

Adjuvant Therapeutics General Information


Developer of a cancer treatment technology designed to improve cancer treatment. The company's technology offers a system called OncO2, that increase oxygen concentrations in tumors, enabling physicians to improve the effectiveness of radiotherapy for cancer treatment.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Devices and Supplies
Primary Office
  • 1344 Summer Street
  • Suite 311.1
  • Halifax, Nova Scotia B3H 0A8
  • Canada

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Adjuvant Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Feb-2018 Completed Out of Business
1. Accelerator/Incubator Completed Startup
To view Adjuvant Therapeutics’s complete valuation and funding history, request access »

Adjuvant Therapeutics Executive Team (1)

Name Title Board Seat Contact Info
Cliff Ansel Chief Executive Officer
To view Adjuvant Therapeutics’s complete executive team members history, request access »

Adjuvant Therapeutics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial